Stay updated on Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial page.

Latest updates to the Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedRevision update from v3.4.3 to v3.5.0; no substantive changes to the page content or study information are evident.SummaryDifference0.1%

- Check16 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding/operating status notice (Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check51 days agoChange DetectedA site-wide notice informs users about a lapse in government funding and NIH status, and the page shows a revision to version 3.4.1 (replacing 3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check58 days agoChange DetectedThe page now shows a Show glossary option and includes minor metadata label changes (Last Update Submitted that Met QC Criteria, No FEAR Act Data) with a new Revision: v3.4.0. These changes are UI-related and do not modify the study content, outcomes, or eligibility criteria.SummaryDifference0.2%

- Check72 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4. No substantive study content or page functionality changes were observed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial page.